Xi'an Medical University

What Xi'an Medical University does

Xi'an Medical University is a provincial public medical university in Xi'an, Shaanxi Province, China, founded in 1951 as the Shaanxi Provincial Health Technical School and upgraded to its current university status in 2006. It serves as the primary medical education institution in Shaanxi Province, delivering undergraduate and graduate medical education across 20 undergraduate majors through 16 teaching units, with current enrollment of 15,533 undergraduates and 973 graduate students (2026). The university operates three campuses (Weiyang, Hanguang, Gaoxin) and runs a deeply integrated clinical training ecosystem comprising 6 directly affiliated hospitals, 33 teaching hospitals, and 66 off-campus practice bases, supporting 902 full-time faculty members. The institution holds three ESI global top 1% discipline rankings (Clinical Medicine, Pharmacology and Toxicology, Biology and Biochemistry), operates a National Drug Clinical Trial Institution, and holds 665 national patents with 130+ technology transfer achievements.

The university's business model is anchored on provincial government budget allocation as its primary funding source, supplemented by tuition and fees from domestic students, healthcare services revenue from affiliated hospitals, research grants and horizontal contracts with enterprises, and continuing education income. In 2026, the university established the London Met Health Institute jointly with London Metropolitan University — the first Sino-foreign cooperative medical education institution in Shaanxi Province — offering premium-priced dual-degree programs in Pharmacy, Rehabilitation Therapy, and Cancer Immunotherapy (60,000–75,000 RMB/year), representing a new revenue diversification channel. The go-to-market motion relies on the national Gaokao admission system for domestic undergraduates, self-administered assessments for graduate and international programs, and educational expos for international student recruitment. The institution has trained over 150,000 medical professionals since founding, with graduates covering all county-level areas in Shaanxi Province and an alumni employment rate maintained above 90%. It is also a member of the Belt and Road International Medical Education Alliance and collaborates with 31 international partner universities.

Customer segments are segmented by use case: domestic undergraduate and graduate students (primary), international students and dual-degree seekers via the London Met joint program (secondary), practicing healthcare professionals seeking continuing education (secondary), and the Shaanxi provincial healthcare system as a workforce development partner. Marketing channels are primarily traditional — educational expos, campus open days, official website, WeChat public account, and dedicated program websites. The university has no parent company in the corporate sense; it is governed by the Shaanxi Provincial People's Government, with a Party Committee-led leadership structure.

Name

Xi'an Medical University

Legal name

西安医学院

Website

https://xiyi.edu.cn

Company type

Private

Founded year

1951

Operating status

Operating

Headcount range

101–250 employees

Short description

Xi'an Medical University is a Shaanxi provincial public medical university (founded 1951) serving as the primary medical education and clinical training institution for the province, delivering undergraduate and graduate programs across three Xi'an campuses, supported by 6 affiliated hospitals and 31 international partner universities.

Ownership category

akta.pro rank

Product category

Higher Education

NAICS

Colleges, Universities, and Professional Schools (6113), General Medical and Surgical Hospitals (622110)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Health Services (8000)

akta.pro industry

PRIMARYEDAHAGAA

Academic Medical Centers & Teaching Hospitals (University-Affiliated)

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

SECONDARYEDAHAGAB

Medical Schools (MD/DO Granting)

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

SECONDARYEDAHAGAI

Biomedical Sciences & Medical Research Institutes (University-Based)

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

Keywords

• Medical education
• Higher education
• Clinical training
• Pharmacy programs
• Rehabilitation therapy

Headquarters

HQ city

Xi'an

HQ country

China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Tuition and fees: Revenue from undergraduate and graduate tuition fees from domestic and international students
2. Government public budget allocation: Annual public budget拨款 from Shaanxi Provincial Government for higher education operations
3. Educational事业收入: Revenue from educational activities including continuing education and training programs
4. Healthcare services: Revenue from affiliated hospitals providing medical services
5. Research grants and contracts: Funding from national, provincial and municipal research projects, as well as horizontal research contracts with enterprises

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Xi'an Medical University is a public medical university offering undergraduate, graduate, and continuing education programs across medical disciplines including clinical medicine, nursing, pharmacy, preventive medicine, and rehabilitation therapy. It delivers academic instruction across three Xi'an campuses combined with clinical training at 6 affiliated hospitals and 33 teaching hospitals, and in 2026 launched the London Met Health Institute—a joint institute with London Metropolitan University offering dual-degree programs in Pharmacy, Rehabilitation Therapy, and Cancer Immunotherapy.

Product overview

Xi'an Medical University is a provincial medical university in Shaanxi Province, China, offering undergraduate, graduate, and continuing education programs. The university's main academic offerings include clinical medicine, nursing, pharmacy, preventive medicine, and other medical programs. A notable recent development is the London Metropolitan Health Institute, a joint program with UK partner London Metropolitan University offering dual-degree programs in Pharmacy, Rehabilitation Therapy (undergraduate), and Cancer Immunotherapy (master's level). The university also provides digital library resources including CNKI, Wanfang, and various database access through its library system.

Differentiator

Problem solved

Functional benefit

Products and services

• London Met Health Institute Joint Programs (西安医学院伦敦城市健康学院) A non-independent Chinese-foreign cooperative education institution jointly established by Xi'an Medical University and London Metropolitan University, offering undergraduate programs in Pharmacy and Rehabilitation Therapy (4+0 model) and a master's program in Cancer Immunotherapy (2+0 model). Students earn dual degrees from both institutions without requiring overseas study. Priced at 60,000 yuan/year for undergraduate programs and 75,000 yuan/year for the master's program.
• Pharmacy Undergraduate Program (London Met Health Institute) A 4-year undergraduate program in Pharmacy offered through the London Met Health Institute joint institute, combining Chinese and UK curricula. Students study entirely in China and receive dual degrees from both institutions. Enrolls 120 students per year at 60,000 yuan/year tuition.
• Rehabilitation Therapy Undergraduate Program (London Met Health Institute) A 4-year undergraduate program in Rehabilitation Therapy offered through the London Met Health Institute joint institute, focusing on physical therapy and rehabilitation sciences with dual-degree outcomes. Enrolls 80 students per year at 60,000 yuan/year tuition.
• Cancer Immunotherapy Master's Program (London Met Health Institute) A 2-year Master's program in Cancer Immunotherapy offered through the London Met Health Institute joint institute, focusing on tumor immunology research and clinical applications. Students earn a UK Master's degree without studying abroad. Total program tuition is 150,000 yuan (75,000 yuan/year).
• Xi'an Medical University Library Digital Resources Comprehensive digital library services including CNKI, Wanfang Data, Chinese Biomedical Literature Service System, Springer Link, and various other academic databases available to students and faculty. Supports 1.31 million paper books and 2.3 million+ e-books across library collections.
• Zhangyue Reading Platform (掌阅精选) Digital reading platform providing access to 50,000 e-books including bestsellers, educational materials, and classic literature, available via mobile app and PC access for students and faculty.

Quantifiable outcome

• Over 150,000 medical talents trained and deployed since founding
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eight partnerships are on record, tiered moderate, core and minor.

• UK Embassy and British Business Trade DepartmentmoderateStrategic or Co-development Partner · 2 July 2026Supported UK-Shaanxi Education and Skills Cooperation Exchange event, facilitated by British Embassy Commercial Department and Shaanxi Provincial Foreign Affairs Office, Education Department, and International Education Exchange Association.
• London Metropolitan University (英国伦敦城市大学)coreStrategic or Co-development Partner · 25 May 2026Joint establishment of London Met Health Institute (西安医学院伦敦城市健康学院) - the first medical joint program in Shaanxi Province, approved by Ministry of Education. Offers undergraduate programs in Pharmacy and Rehabilitation Therapy (4+0 model) and master's in Cancer Immunotherapy (2+0 model). Programs approved through formal Chinese-British joint certification process.
• Belt and Road International Medical Education Alliance (一带一路国际医学教育联盟)moderateStrategic or Co-development PartnerUniversity is an active member of this international education organization focused on medical education cooperation along the Belt and Road.
• 31 international partner universitiesmoderateStrategic or Co-development PartnerStrategic collaboration with 31 foreign universities and institutions in talent cultivation, scientific research, and discipline development including partnerships in US, South Korea, Italy, and other countries.
• Panlong Pharmaceutical Group (盘龙药业)minorStrategic or Co-development PartnerEnterprise collaboration for technology research and achievement transfer, including joint technical tackling projects.
• Disai Pharmaceutical (迪赛药业)minorStrategic or Co-development PartnerEnterprise collaboration for pharmaceutical technology development and transfer.
• International Creative College (ICC) Project partnersmoderateChannel Partner/ Reseller/ DistributorPartnership with China Education International Exchange Association to operate ICC (International Creative College) project offering 6 programs: Nursing, Pharmacy, Medical Laboratory Technology, Medical Imaging Technology, Rehabilitation Therapy, and Public Service Management.
• 167 primary healthcare units in Western Medicine Primary Healthcare AlliancemoderateStrategic or Co-development PartnerAlliance led by university connecting 167 primary healthcare units and 2 tertiary hospitals for grassroots medical service support, conducting over 300 free consultations annually benefiting approximately 20,000 people.

Scale indicators13 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Wenzhou Medical University: Provincial medical university in Zhejiang with similar scale (~17,000 students), provincial-government backing, and a comparable mix of clinical medicine, pharmacy, and rehabilitation programs. Closest direct tier-competitor to Xi'an Medical University.
• Weifang Medical University: Smaller provincial medical university in Shandong with a similar governance and funding model. Comparable in scale and program mix, and a relevant peer for evaluating tier-2 provincial medical-school positioning.
• Guangzhou Medical University: Provincial medical university in Guangdong with comparable scale and program mix. Comparable in terms of provincial-government funding model, affiliated-hospital network, and emphasis on clinical medicine and public health.
• Anhui Medical University: Provincial medical university in Anhui with comparable enrollment scale, similar affiliated-hospital network, and overlapping programs in clinical medicine, pharmacy, and public health. Direct competitor for tier-2 medical-school applicants and faculty.
• Nanjing Medical University: Provincial medical university in Jiangsu with a similar governance model, scale, and discipline mix (clinical medicine, pharmacy, public health). Competes for the same tier of national applicants and faculty candidates.
• Tianjin Medical University: Municipal-level medical university with comparable scale and provincial-equivalent funding. Direct tier competitor with overlapping research strengths and program offerings in clinical medicine, pharmacy, and biomedical sciences.
• Chongqing Medical University: Larger but tier-comparable provincial medical university serving Southwest China. Operates a similarly broad set of medical, pharmacy, and public-health programs and competes for the same pool of national-level medical-school applicants.

Broad incumbents

• Capital Medical University: Beijing-based municipal medical university with deeper resources, larger affiliated-hospital network, and higher national ranking. Represents the broader incumbent benchmark in terms of scale, research output, and applicant quality.
• China Medical University: Higher-ranked national-level medical university serving as a benchmark for research output and faculty quality. Sets the upper bound for what a Chinese medical school can achieve in ESI rankings, research grants, and brand prestige.

Regional players

• Shaanxi University of Chinese Medicine: Co-located medical university in Shaanxi Province focused on Traditional Chinese Medicine. Regional peer competing for the same provincial applicant pool and government funding, though differentiated by TCM versus Western medicine orientation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/school/%E8%A5%BF%E5%AE%89%E5%8C%BB%E5%AD%A6%E9%99%A2

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xi'an Medical University